Vanguard Complete Knee Solution
Device Knees
PDI 00887868262265
General payments
$5,892,118
Research payments
$129,067
Through program year 2025, $5,892,118 in general payments and $129,067 in research payments were reported against Vanguard Complete Knee Solution (Knees).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $13,696 | 4 |
| 2024 | General | $30,886 | 24 |
| 2024 | Research | $127,672 | 1 |
| 2023 | General | $3,231,744 | 23 |
| 2023 | Research | $1,395 | 1 |
| 2022 | General | $2,615,792 | 53 |
Breakdown
Each share is of general payments naming this product in 2025.
Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2025 where a state was reported.
Records
104 general · 2 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.